Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children

被引:8
|
作者
Laub, Otto [1 ]
Leipold, Georg [2 ]
Toncheva, Antoaneta A. [3 ]
Peterhoff, David [4 ,5 ]
Einhauser, Sebastian [4 ]
Neckermann, Patrick [4 ]
Borchers, Natascha [3 ]
Santos-Valente, Elisangela [3 ]
Kheiroddin, Parastoo [3 ]
Buntrock-Doepke, Heike [3 ,6 ]
Laub, Sarah [1 ]
Schoeberl, Patricia [3 ,6 ]
Schweiger-Kabesch, Andrea [3 ]
Ewald, Dominik [7 ]
Horn, Michael [8 ]
Niggel, Jakob [9 ]
Ambrosch, Andreas [10 ]
Ueberla, Klaus [11 ,12 ]
Gerling, Stephan [3 ]
Brandstetter, Susanne [3 ,6 ]
Wagner, Ralf [4 ,5 ]
Kabesch, Michael [3 ,6 ]
机构
[1] Pediat Off Laub, Rosenheim, Germany
[2] Pediat Off Dr Leipold, Regensburg, Germany
[3] Univ Regensburg, Hosp St Hedwig Order St John, Univ Childrens Hosp Regensburg KUNO, Regensburg, Germany
[4] Univ Regensburg, Inst Med Microbiol & Hyg, Mol Microbiol Virol, Regensburg, Germany
[5] Univ Hosp, Inst Clin Microbiol & Hyg, Regensburg, Germany
[6] Hosp St Hedwig Order St John, Res & Dev Campus Regensburg WECARE, Regensburg, Germany
[7] Pediat Off Dr Heuschmann & Dr Ewald, Regenstauf, Germany
[8] Pediat Off Dr Horn, Schonau, Germany
[9] Maganamed Ltd, Regensburg, Germany
[10] Hosp Order St John, Inst Lab Med Microbiol & Hyg, Regensburg, Germany
[11] FAU Erlangen Nuremberg, Inst Clin & Mol Virol, Erlangen, Germany
[12] Univ Klinikum Erlangen, Erlangen, Germany
来源
FRONTIERS IN PEDIATRICS | 2021年 / 9卷
关键词
antibody; neutralizing; COVID-19; SARS-CoV-2; children;
D O I
10.3389/fped.2021.678937
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in children. Methods: In a cross-sectional design, children aged 1-17 were recruited through primary care pediatricians for the study (a) randomly, if they had an appointment for a regular health check-up or (b) if parents and children volunteered and actively wanted to participate in the study. Symptoms were recorded and two antibody tests were performed in parallel directed against S (in house test) and N (Roche Elecsys) viral proteins. In children with antibody response in either test, neutralization activity was determined. Results: We identified antibodies against SARS-CoV-2 in 162 of 2,832 eligible children (5.7%) between end of May and end of July 2020 in three, in part strongly affected regions of Bavaria in the first wave of the pandemic. Approximately 60% of antibody positive children (n = 97) showed high levels (>97th percentile) of antibodies against N-protein, and for the S-protein, similar results were found. Sufficient neutralizing activity was detected for only 135 antibody positive children (86%), irrespective of age and sex. Initial COVID-19 symptoms were unspecific in children except for the loss of smell and taste and unrelated to antibody responses or neutralization capacity. Approximately 30% of PCR positive children did not show seroconversion in our small subsample in which PCR tests were performed. Conclusions: Symptoms of SARS-CoV-2 infections are unspecific in children and antibody responses show a dichotomous structure with strong responses in many and no detectable antibodies in PCR positive children and missing neutralization activity in a relevant proportion of the young population.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study
    Dumont, Roxane
    Nehme, Mayssam
    Lorthe, Elsa
    De Mestral, Carlos
    Richard, Viviane
    Baysson, Helene
    Pennacchio, Francesco
    Lamour, Julien
    Semaani, Claire
    Zaballa, Maria-Eugenia
    Pullen, Nick
    Perrin, Anne
    L'Huillier, Arnaud G.
    Posfay-Barbe, Klara Maria
    Guessous, Idris
    Stringhini, Silvia
    BMJ OPEN, 2022, 12 (11):
  • [2] Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study
    Nah, Eun-Hee
    Cho, Seon
    Park, Hyeran
    Hwang, Inhwan
    Cho, Han-Ik
    BMJ OPEN, 2021, 11 (04):
  • [3] Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
    Dora Pinto
    Young-Jun Park
    Martina Beltramello
    Alexandra C. Walls
    M. Alejandra Tortorici
    Siro Bianchi
    Stefano Jaconi
    Katja Culap
    Fabrizia Zatta
    Anna De Marco
    Alessia Peter
    Barbara Guarino
    Roberto Spreafico
    Elisabetta Cameroni
    James Brett Case
    Rita E. Chen
    Colin Havenar-Daughton
    Gyorgy Snell
    Amalio Telenti
    Herbert W. Virgin
    Antonio Lanzavecchia
    Michael S. Diamond
    Katja Fink
    David Veesler
    Davide Corti
    Nature, 2020, 583 : 290 - 295
  • [4] Neutralization of SARS-CoV-2 infection by antibodies targeting diverse epitopes
    Wang, Shusheng
    Liao, Yunji
    Yang, Kaiyong
    Ma, Hang
    Song, Zhangyi
    Huang, Haiqiu
    Zhang, Li
    Wang, Ailing
    Han, Lei
    Zhang, Jiawei
    Chen, Hui
    Yin, Haiyang
    Bian, Yanlin
    Jiang, Hua
    Xiao, Xiaodong
    Xie, Yueqing
    Yuan, Yunsheng
    Zhu, Jianwei
    GENES & DISEASES, 2024, 11 (04)
  • [5] Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
    Ebinger, Joseph E.
    Botwin, Gregory J.
    Albert, Christine M.
    Alotaibi, Mona
    Arditi, Moshe
    Berg, Anders H.
    Binek, Aleksandra
    Botting, Patrick
    Fert-Bober, Justyna
    Figueiredo, Jane C.
    Grein, Jonathan D.
    Hasan, Wohaib
    Henglin, Mir
    Hussain, Shehnaz K.
    Jain, Mohit
    Joung, Sandy
    Karin, Michael
    Kim, Elizabeth H.
    Li, Dalin
    Liu, Yunxian
    Luong, Eric
    McGovern, Dermot P. B.
    Merchant, Akil
    Merin, Noah
    Miles, Peggy B.
    Minissian, Margo
    Nguyen, Trevor Trung
    Raedschelders, Koen
    Rashid, Mohamad A.
    Riera, Celine E.
    Riggs, Richard, V
    Sharma, Sonia
    Sternbach, Sarah
    Sun, Nancy
    Tourtellotte, Warren G.
    Van Eyk, Jennifer E.
    Sobhani, Kimia
    Braun, Jonathan G.
    Cheng, Susan
    BMJ OPEN, 2021, 11 (02): : e043584
  • [6] Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
    Li, Ruofan
    Mor, Michael
    Ma, Bingting
    Clark, Alex E.
    Alter, Joel
    Werbner, Michal
    Lee, Jamie Casey
    Leibel, Sandra L.
    Carlin, Aaron F.
    Dessau, Moshe
    Gal-Tanamy, Meital
    Croker, Ben A.
    Xiang, Ye
    Freund, Natalia T.
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [7] Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
    Ruofan Li
    Michael Mor
    Bingting Ma
    Alex E. Clark
    Joel Alter
    Michal Werbner
    Jamie Casey Lee
    Sandra L. Leibel
    Aaron F. Carlin
    Moshe Dessau
    Meital Gal-Tanamy
    Ben A. Croker
    Ye Xiang
    Natalia T. Freund
    Communications Biology, 5
  • [8] Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals
    Zhu, Yuanmei
    Yu, Danwei
    Han, Yang
    Yan, Hongxia
    Chong, Huihui
    Ren, Lili
    Wang, Jianwei
    Li, Taisheng
    He, Yuxian
    SCIENCE ADVANCES, 2020, 6 (45)
  • [9] Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies
    Lou, Yan
    Zhao, Wenxiang
    Wei, Haitao
    Chu, Min
    Chao, Ruihua
    Yao, Hangping
    Su, Junwei
    Li, Yanan
    Li, Xiulan
    Cao, Yu
    Feng, Yanyan
    Wang, Ping
    Xia, Yongyang
    Shang, Yushuan
    Li, Fengping
    Ge, Pingju
    Zhang, Xinglin
    Gao, Wenjing
    Song, Gaojie
    Du, Bing
    Liang, Tingbo
    Qiu, Yunqing
    Liu, Mingyao
    BIOTECHNOLOGY JOURNAL, 2021, 16 (11)
  • [10] Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
    Roarty, Cathal
    Tonry, Claire
    McFetridge, Lisa
    Mitchell, Hannah
    Watson, Chris
    Waterfield, Thomas
    LANCET INFECTIOUS DISEASES, 2021, 21 (06): : E143 - E143